NDC 44911-0631
Influenzinum 200C
Influenzinum (2020-2021)
Influenzinum 200C is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Energique, Inc.. The primary component is Influenza A Virus A/guangdong-maonan/swl1536/2019 Cnic-1909 (h1n1) Antigen (formaldehyde Inactivated); Influenza A Virus A/hong Kong/2671/2019 Ivr-208 (h3n2) Antigen (formaldehyde Inactivated); Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated); Influenza B Virus B/washington/02/2019 Antigen (formaldehyde Inactivated).
| Product ID | 44911-0631_685ce6cf-ed03-4913-85bb-f6de4585a001 |
| NDC | 44911-0631 |
| Product Type | Human Otc Drug |
| Proprietary Name | Influenzinum 200C |
| Generic Name | Influenzinum (2020-2021) |
| Dosage Form | Liquid |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-12-30 |
| Marketing End Date | 2026-01-05 |
| Marketing Category | UNAPPROVED HOMEOPATHIC / |
| Labeler Name | Energique, Inc. |
| Substance Name | INFLUENZA A VIRUS A/GUANGDONG-MAONAN/SWL1536/2019 CNIC-1909 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED) |
| Active Ingredient Strength | 200 [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL |
| NDC Exclude Flag | N |